Treatment delayed tumor growth, while also inhibiting lung metastasis, reducing splenomegaly, increasing activated IFNγ+ CD4+ and CD8+ splenocytes, and increasing tumor infiltrating CD8+ T cells (72). The gene discussed is CD8A; the disease is neoplasm.